207_Combined course Presentations

“Genome-Forward” Trials

2 baseline frozen cores 70%+ tumor cellularity DNA extracted

Ki67 in surgical sample Greater that 10% = Unfavorable

16 to 18 weeks of aromatase inhibition

2 baseline frozen cores 70%+ tumor cellularity DNA extracted

Ki67 in surgical sample Less than10% = Favorable

BCRF, NHGRI, NCI

Made with